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ABSTRACT  
There is a deficiency of knowledge regarding how traumatic brain injury (TBI) is 
associated with age at onset (AAO) of cognitive impairment in older adults. 
Participants with a TBI history were identified from the Alzheimer’s Disease 
Neuroimaging Initiative (ADNI 1/GO/2) medical history database. Using an 
analysis of covariance (ANCOVA) model, the AAO was compared between those 
with and without TBI, and potential confounding factors were controlled. The 
AAO was also compared between those with mild TBI (mTBI) and moderate or 
severe TBI (sTBI). Lastly, the effects of mTBI were analyzed on the AAO of 
participants with clinical diagnoses of either mild cognitive impairment (MCI) or 
Alzheimer’s disease (AD). The AAO for the TBI group was 68.2 ± 1.1 years (95% 
confidence interval (CI): 66.2-70.3, n=62), which was significantly earlier than the 
AAO for the non-TBI group of 70.9 ± 0.2 years (95% CI: 70.5-71.4, n=1197) 
(p=0.013). Participants with mTBI history showed an AAO of 68.5 ± 1.1 years 
(n=56), which was significantly earlier than the AAO for the non-TBI group 
(p=0.032). Participants with both MCI and mTBI showed an AAO of 66.5 ± 1.3 
years (95% CI: 63.9-69.1, n=45), compared to 70.6 ± 0.3 years for the non-TBI 
MCI group (95% CI: 70.1-71.1, n=935) (p=0.016). As a conclusion, a history of 
TBI may accelerate the AAO of cognitive impairment by 2 or more years. These 
results were consistent with reports of TBI as a significant risk factor for cognitive 
decline in older adults and TBI is associated with an earlier AAO found in 
patients with MCI or AD. 
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Introduction 
Traumatic brain injury (TBI) has been studied as a risk factor associated with 
cognition deterioration for several decades [1]. However, the details of how TBI 
associates with onset of cognitive impairment is still unclear due to a number of 
factors such as varied criteria for defining TBI severity [2], as well as various 
types and severity of cognitive impairment. A history of TBI has been found to 
correlate with an elevated risk for developing cognitive impairment [3-7]. For 
example, a 5-year follow-up study found that TBI could increase the risk of 
developing dementia by 1.7 fold after adjusting for covariates [8]. The dementia 
associated with TBI could be either the Alzheimer’s disease (AD) type or the non-
AD type [2, 9, 10]. The TBI severity plays an important role for dementia 
development [2, 5, 11]. Moderate to severe TBI (sTBI) was confirmed as a risk 
factor for developing dementia [5, 12, 13]. Even mild TBI (mTBI) was shown as 
an independent significant risk factor for developing dementia with a hazard ratio 
between 1.6 and 3 [2, 14, 15]. In this study, we tested the hypothesis that a 
history of TBI and the severity of TBI are associated with the age at onset (AAO) 
of cognitive impairment in older adults. In addition, we assessed whether mTBI 
influences the AAO in patients with clinical diagnoses of cognitive impairment 
(mild cognitive impairment (MCI) versus or AD). 
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Methods 
Alzheimer’s Disease Neuroimaging Initiative (ADNI) 
Data used in preparation of this article were obtained from the ADNI database 
(adni.loni.usc.edu). The ADNI was launched in 2003 and has been sponsored by 
the National Institute on Aging (NIA), the National Institute of Biomedical Imaging 
and Bioengineering (NIBIB), the Food and Drug Administration (FDA), private 
pharmaceutical companies and non-profit organizations. The primary goal of 
ADNI has been to test whether serial magnetic resonance imaging (MRI), 
positron emission tomography (PET), other biological markers, and clinical and 
neuropsychological assessment can be combined to measure the progression of 
MCI and early AD. ADNI is the result of efforts of many co-investigators from a 
broad range of academic institutions and private corporations, and subjects have 
been recruited from over 50 sites across the U.S. and Canada. The initial goal of 
ADNI was to recruit 800 subjects but ADNI has been followed by ADNI-GO and 
ADNI-2. To date these three protocols have recruited over 1500 adults, ages 55 
to 90, to participate in the research, consisting of cognitively normal older 
individuals, people with early or late MCI, and people with early AD. The follow 
up duration of each group is specified in the protocols for ADNI-1, ADNI-2 and 
ADNI-GO. Subjects originally recruited for ADNI-1 and ADNI-GO had the option 
to be followed in ADNI-2. Further information can be found at http://www.adni-
info.org/ and in previous reports [16-21]. 
Selection of Participants with a TBI History 
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Self-reported medical history data were collected from all participants at all ADNI 
clinical sites. Both participants and their study partners (informants) were the 
sources of the medical history information. We assessed all participants first for 
history of TBI, subsequently including only those with cognitive impairment (e.g. 
MCI and AD) in whom AAO was recorded. Therefore, the final sample included 
81 participants with a history of TBI. Demographic and clinical information for the 
81 participants with TBI history was summarized in Table 1. The age at injury of 
TBI showed a bimodal distribution and the average age at injury is 35.4 ± 24.8 
years old. According to the Mayo Clinic TBI standards [22], 8 of these 81 
participants have a diagnosis of sTBI and 73 participants had mTBI. 
Data Analyses 
AAO referred to the age at which a participant first reported cognition 
impairments for: 
 a memory complaint reported by either participant or informant; and 
 an objective memory loss measured by education adjusted scores on 
delayed recall of one paragraph from Wechsler Memory Scale Logical 
Memory II (between approximately 0.5 and 1.5 standard deviation below 
the mean of normal cognition); and  
 a clinical dementia rating of 0.5 or more.  
The AAO was the dependent variable in all analyses and results were presented 
in the format of mean ± standard error. In total, 19 of the 81 participants with TBI 
history were recruited as healthy control participants and thus, did not have a 
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reported AAO. Therefore, the final sample of participants with a reported AAO 
includes 1197 without a TBI history and 62 with a TBI history. 
The following analyses were completed using SPSS version 22.0. First, the AAO 
was compared between the TBI and the non-TBI groups by one-way univariate 
ANCOVA analysis with gender, years of education, APOE 4 carrier status (+/-), 
and baseline diagnosis group as covariates. Then, the AAO was compared 
among non-TBI (n=1192), mTBI (n=62), and sTBI (n=6) using a one-way 
univariate ANCOVA analysis covaried for gender, years of education, APOE 4 
carrier status (+/-), and baseline diagnosis group. Lastly, the effects of mTBI on 
AAO were studied in participants with either AD or MCI using a two-way 
ANCOVA model (cognition diagnosis by TBI status) with controlling for gender, 
years of education, and APOE 4 carrier status (+/-). The Bonferroni test was 
used for post-hoc comparisons between subgroups. The significance level of p 
value < 0.05 was set for all analyses, and all graphs were created by using 
Sigmaplot version 10.0.  
 
 
Results 
 
An earlier AAO of cognitive impairment is associated with a TBI history 
 
The AAO of cognitive impairment was compared between participants with TBI 
(TBI) or without TBI (non-TBI). The TBI group (n=62) had a significantly earlier 
AAO of 68.2 ± 1.1 years (95% confidence interval (CI): 66.2-70.3, n=62) than the 
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non-TBI group (AAO: 70.9 ± 0.2 years; 95% CI: 70.5-71.4; n=1197; p=0.013) 
(Fig1 and Table 2).  
mTBI but not sTBI is related to an earlier AAO of cognitive impairment 
Then the effects of TBI severity were investigated by comparing the AAOs 
among participants without TBI (none), with mTBI, or with sTBI. The AAO for 
non-TBI group was 70.9 ± 0.2 years (95% CI: 70.5-71.4; n=1197) and the AAO 
was 68.5 ± 1.1 years for mTBI group (95% CI: 66.3-70.7; n=56). For the sTBI 
group, the AAO was 66.0 ± 3.4 years (95% CI: 59.3-72.6, n=6). The more severe 
the TBI, the earlier an AAO was observed for the participants with a TBI history, 
although only non-TBI group and the mTBI group have significantly different 
AAOs (p=0.032) (Fig2 and Table 2).  
mTBI is associated with an earlier AAO in participants with MCI 
Based on having mTBI or not, participants with cognitive impairment (MCI or AD) 
were divided into four subgroups: MCI, MCI + mTBI, AD and AD + mTBI.  
The AAOs for these four groups were as follows: 70.6 ± 0.3 years for the MCI 
group (95% CI: 70.1-71.1, n=935); 66.5 ± 1.3 years for the mTBI + MCI group 
(95% CI: 63.1-69.1, n=45); 72.3 ± 0.6 years for the AD group (95% CI: 71.1-73.5, 
n=193); and 70.2 ± 2.6 years for the mTBI + AD group (95% CI: 65.1-75.3, 
n=10). The participants with both MCI and mTBI history showed a significantly 
earlier AAO than the MCI group of approximately 4 years (p=0.016). Participants 
with both AD and mTBI history had an earlier AAO (< 2 years) than the AD 
group. However, the difference was not statistically significant (Fig3 and Table 2). 
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Discussion 
Previous studies have shown that TBI is an important risk factor for developing 
either AD or non-AD type dementia [2, 9, 10]. There has been less research 
quantifying how TBI or severity of TBI is associated with the AAO of cognitive 
impairment [11]. In our retrospective study, participants with a TBI history had an 
accelerated AAO of cognitive impairment. In considering possible mechanisms of 
impact on onset of cognitive decline, we note that in humans, axons damaged by 
TBI have been shown to serve as a large reservoir of amyloid-beta, which may 
explain the observed amyloid plaques found in the brains of TBI subjects [23]. In 
a rat model, the overexpression of amyloid-beta precursor protein (APP) was 
also observed following TBI [24]. Since the presence of amyloid-beta plaques is 
a key feature of AD, these data indirectly support TBI as a risk factor for 
associating with cognition deterioration as well as an earlier AAO than in older 
adults without a TBI history. 
Although the sTBI group shows a trend of having an earlier AAO than the mTBI 
group, the present study did not have sufficient power to test the difference. The 
sample size for the sTBI group is small due to the enrollent criteria for the ADNI. 
Participants with a history of significant head trauma followed by persistent 
neurologic deficits or known structural brain abnormalities were excluded from 
the ADNI (see exclusion criteria in the protocols for the ADNI 1/GO/2). An 
underlying mechanism for developing cognitive impairments from mTBI was 
suggested by findings that white matter abnormalities from symptomatic mTBI 
patients show a similar distribution pattern as in early AD type dementia [25]. By 
contrast, severe TBIs can initiate AD-type pathological processes as an acute 
10 
 
phase response to TBI by overexpressing APP and leading to amyloid-beta 
plaque deposition [26]. Both mTBI and sTBI appeared to influence onset of 
cognitive decline, although the difference between AAOs based on TBI severity 
was not significant in this study. 
Although some symptoms from mTBI can be resolved within a few months post-
injury [1], a history of mTBI was shown to be associated with a significantly 
earlier AAO of cognitive impairment by more than 4 years in patients with a 
cognition diagnosis of MCI. The mTBI has a smaller non-significant effect (less 
than 2 years) on the AAO of cognitive impairment observed in patients with a 
diagnosis of AD. 
Our findings have important implications for clinical diagnosis and prognosis, as 
well as for applying therapeutic interventions to decrease the likelihood of 
developing cognition impairments after TBI. As for any retrospective study, one 
limitation for this study comes from the possible recall bias for either TBI history 
or cognitive symptoms, which were reported by the participants. The second 
limitation is that the effects of mTBI on AAO were only studied in patients with 
either MCI or AD. Individuals with TBI could have different etiologies for cognitive 
impairment other than AD or chronic traumatic encephalopathy (CTE) [27]. For 
example, frontotemporal dementia is seen more often in those with TBI than in 
those without a TBI history [28, 29]. However, the manner by which TBI affects 
risk for other types of dementia or cognitive impairment is beyond the scope of 
this study because it was performed in an MCI/AD cohort. In addition, this study 
did not control for other possible confounding factors that might affect the AAO of 
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cognitive impairment as well such as alcoholism, hypertension, stroke and type 2 
diabetes mellitus [30-33].  
Our study demonstrated TBI as a risk factor associated with an earlier AAO of 
cognitive impairment. Even a history of mTBI was shown to significantly 
accelerate the AAO of cognitive impairment. Lastly, mTBI was shown to 
acclerate the AAO in patients with MCI. The cognitive symptoms seen in people 
with a TBI history may be associated with a common sequelae of head injury: 
namely depression [7, 34], which was not investigated further in the current 
study. The quantification information regarding how TBI assoicates with an 
earlier AAO of cognitive impairment may be useful for clinicans to make a more 
accurate prognosis or take appropriate preventative or therapeutic measures for 
TBI patients. The roles of moderate or severe TBIs on cogntion impairments are 
worthy to be studied with a larger sample in the future. Finally, the observed 
association between TBI and AAO of cognitive impairment need further 
confirmation by studies investigating biomarker changes and studies assesssing 
pathological changes at autopsy. 
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Fig1. An earlier AAO was found in participants with a TBI history.  
 
The AAOs were compared between participants with and without (none) a TBI 
history. AAO: age at onset; None: participants without TBI; TBI: participants with 
a history of traumatic brain injury 
 
 
Fig2. The AAO varied with changes in the severity of TBI. 
 
The AAOs were compared among three groups of participants (none, mTBI, and 
sTBI). AAO: age at onset; None: participants without TBI; mTBI: mild TBI; TBI: 
moderate or severe TBI 
 
Fig3. mTBI was associated with an earlier AAO in participants with MCI. 
 
The effects of mTBI on AAO were studied among participants with cognitive 
symptoms (MCI or AD). The participants were divided into four subgroups (MCI, 
MCI + mTBI, AD and AD + mTBI). AAO: age at onset; MCI: mild cognitive 
impairment; mTBI: mild TBI; AD: Alzheimer’s disease 
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Table1. Demographic and clinical information was shown for the ADNI 
participants.  
Participant group TBI (n=81) Non-TBI (n=1197) 
Gender (male: female) 58 (71.6%): 23 
(28.4%) 
677 (56.56%): 520 
(43.44%) 
Education (mean ± SD) 16 ± 3 16 ± 3 
 MCI: AD (baseline 
diagnosis group) 
45 (81.82%): 10 
(18.18%) 
935 (82.89%): 193 
(17.11%) 
APOE 4 genotype (+/-) 37 (45.68%): 44 
(54.32%) 
646 (53.97%): 551 
(46.03%) 
MMSE Total Score 27.3 ± 2.8 26.5 ± 2.7 
 
No significant difference was found between the TBI and non-TBI groups for any 
of the variables. TBI: traumatic brain injury; mean ± SD: mean ± standard 
deviation; MCI: mild cognitive impairment; AD: Alzheimer’s disease; APOE 4: 
Apolipoprotein epsilon 4; MMSE: mini-mental status examination 
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Table 2. The AAOs of cognitive impairment were shown for different groups. 
 
Group AAO 95% CI N  p  
None 70.9 ± 0.2 70.5 - 71.4 1197  
TBI  68.2 ± 1.1 66.2 - 70.3 62 0.013 (versus the Non-TBI group) 
mTBI 68.5 ± 1.1 66.3 - 70.7 56 0.032 (versus the Non-TBI group) 
sTBI 66.0 ± 3.4 59.3 - 72.6 6  
MCI 70.6 ± 0.3 70.1 - 71.1 935  
mTBI + MCI 66.5 ± 1.3 63.1 - 69.1 45 0.016 (versus the MCI group) 
AD 72.3 ± 0.6 71.1 - 73.5 193  
mTBI + AD 70.2 ± 2.6 65.1 - 73.5 10  
 
AAO: age at onset; TBI: traumatic brain injury; mTBI: mild TBI; sTBI: moderate or severe 
TBI; AAOs were shown as mean ± standard error; CI: confidence interval; MCI: mild 
cognitive impairment; AD: Alzheimer’s disease 
 
 
 
 
 
 
 
